Medical Journals

Gene Therapy for Primary Immunodeficiency Diseases: Recent Progress and Misgivings.

Authors:
  • Ariga Tadashi

From: Department of Pediatrics, Hokkaido University Graduate School of Medicine, Japan. tada-ari@med.hokudai.ac.jp

Current pharmaceutical design

  • Publish Date: 2006
  • ISSN: 1381-6128
  • Volume: 12
  • Issue: 5
  • Pages: 549-56
  • Medium: Print
  • Language: English
  • Citation (JAMA): Ariga Tadashi, et al. Gene Therapy for Primary Immunodeficiency Diseases: Recent Progress and Misgivings.. Curr. Pharm. Des. 2006;12:549-56

Abstract

The progress of clinical gene therapy trials during the last two decades has been remarkable, and its application has also expanded into various fields of human diseases. Among them, hereditary diseases such as the primary immunodeficiency diseases (PID) were considered suitable candidates for gene therapy because the therapeutic strategy was very simple, therefore, effective gene therapy may be obtained without significant difficulty compared to other more complex diseases such as cancer. Indeed, the first clinical gene therapy trial was safely performed and was in part, effective for adenosine deaminase (ADA) deficiency patients, a type of severe combined immunodeficiency diseases (SCID). However, because of certain unforeseen obstacles, it took approximately 10 years until the first curative effects were obtained for gene therapy in patients with X-linked SCID (X-SCID). Here, I review and discuss the background and historical events leading up to PID gene therapy, the safety issues, which unexpectedly arose after the successful report, and finally I will attempt to predict the future trends in this form of gene therapy.

Mesh Headings (Keywords): Animals, Antigens, CD34, Gene Therapy, Hematopoietic Stem Cell Transplantation, Humans, Immunologic Deficiency Syndromes, Infant, Newborn, Male, Retroviridae, Severe Combined Immunodeficiency


Check for Full Text / PubMed Unique Identifier (PMID): 16472146


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.